BFEC
FLNA

Benjamin F. Edwards & Company’s Filana Therapeutics FLNA Stock Holding History

Benjamin F. Edwards & Company’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$12K Buy
934
+781
+510% +$16.5K ﹤0.01% 1685
2024
Q1 		$3K Sell
153
-1,000
-87% -$23K ﹤0.01% 1979
2023
Q4 		$26K Buy
1,153
+1,000
+654% +$21.1K ﹤0.01% 1418
2023
Q3 		$3K Hold
153
– – ﹤0.01% 1642
2023
Q2 		$4K Hold
153
– – ﹤0.01% 1606
2023
Q1 		$4K Hold
153
– – ﹤0.01% 1607
2022
Q4 		$5K Hold
153
– – ﹤0.01% 1586
2022
Q3 		$6K Hold
153
– – ﹤0.01% 1526
2022
Q2 		$4K Hold
153
– – ﹤0.01% 1595
2022
Q1 		$6K Hold
153
– – ﹤0.01% 1491
2021
Q4 		$7K Sell
153
-100
-40% -$5.24K ﹤0.01% 1461
2021
Q3 		$16K Buy
+253
New +$21.1K ﹤0.01% 1285

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Benjamin F. Edwards & Company's FLNA Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Filana Therapeutics (FLNA) stake by 510% in Q2 2024, buying an estimated $16.5K and bringing the position to 934 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1685.

Benjamin F. Edwards & Company first reported a position in FLNA in Q3 2021 and has held it in 12 quarters since. The position peaked at $26K in Q4 2023. 145 funds tracked by Wall St. Rank hold FLNA as of Q2 2024.

  • Benjamin F. Edwards & Company held 934 shares of Filana Therapeutics worth $12K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 781 Filana Therapeutics shares in Q2 2024, an estimated $16.5K.
  • Filana Therapeutics made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1685 holding.
  • Benjamin F. Edwards & Company first reported a position in Filana Therapeutics in Q3 2021 and has held it in 12 quarters since.
  • Benjamin F. Edwards & Company's Filana Therapeutics position peaked at $26K in Q4 2023.
  • 145 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.